A Phase 1, Open-Label, Randomized Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-Up and No Ramp-Up Dosing in Healthy Adult Subjects
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009869/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to assess the tolerability, safety, and pharmacokinetics of
HYQVIA with ramp-up and no ramp-up dosing in healthy adult participants.
提供机构：
Vivli
创建时间：
2024-03-11
